SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Vigil Neuroscience, Inc. (VIGL) .
Criteria proven by this page:
- VALUE (35/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Analyst consensus target $8.00 (-0.6% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 33/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VIGL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.07
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$8.00 (-0.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$-1.01 |
$0.00 |
$-28.55M |
- |
| 2021 |
$-28.24 |
$0.00 |
$-43.25M |
- |
| 2022 |
$-2.14 |
$0.00 |
$-67.73M |
- |
| 2023 |
$-2.13 |
$0.00 |
$-82.64M |
- |
| 2024 |
$-2.07 |
$0.00 |
$-84.26M |
- |
